Sanctuary Advisors LLC Takes Position in Utah Medical Products, Inc. $UTMD

Sanctuary Advisors LLC bought a new position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 7,886 shares of the medical instruments supplier’s stock, valued at approximately $544,000. Sanctuary Advisors LLC owned approximately 0.25% of Utah Medical Products as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Comerica Bank increased its position in Utah Medical Products by 435.6% during the third quarter. Comerica Bank now owns 541 shares of the medical instruments supplier’s stock worth $34,000 after buying an additional 440 shares in the last quarter. Fifth Third Bancorp acquired a new position in shares of Utah Medical Products in the 1st quarter valued at $43,000. BNP Paribas Financial Markets boosted its holdings in Utah Medical Products by 89.6% in the third quarter. BNP Paribas Financial Markets now owns 1,060 shares of the medical instruments supplier’s stock valued at $67,000 after acquiring an additional 501 shares during the last quarter. State of Wyoming purchased a new stake in shares of Utah Medical Products during the 2nd quarter worth about $132,000. Finally, Russell Investments Group Ltd. increased its position in shares of Utah Medical Products by 550.5% in the second quarter. Russell Investments Group Ltd. now owns 2,758 shares of the medical instruments supplier’s stock worth $157,000 after acquiring an additional 2,334 shares in the last quarter. 69.60% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Utah Medical Products from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Utah Medical Products Price Performance

UTMD stock opened at $72.77 on Friday. The firm has a market cap of $231.41 million, a price-to-earnings ratio of 22.19 and a beta of 0.35. Utah Medical Products, Inc. has a 1-year low of $53.66 and a 1-year high of $75.75. The firm has a fifty day moving average price of $70.27 and a two-hundred day moving average price of $67.22.

Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Thursday, July 23rd. The medical instruments supplier reported $0.84 EPS for the quarter. The company had revenue of $8.53 million during the quarter. Utah Medical Products had a return on equity of 8.74% and a net margin of 29.04%.

Utah Medical Products Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 5th. Investors of record on Thursday, September 17th will be given a $0.31 dividend. The ex-dividend date is Thursday, September 17th. This represents a $1.24 annualized dividend and a yield of 1.7%. Utah Medical Products’s dividend payout ratio (DPR) is currently 37.80%.

Utah Medical Products Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).